Skip to content

Moxibustion in the treatment of moderate to severe perennial allergic rhinitis: A case series study

Moxibustion in the treatment of moderate to severe perennial allergic rhinitis: A case series study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083730
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis

Interventions

Moxibustion group:The patient took a supine position and fully exposed the acupuncture points of moxibustion. Nanyang moxa stick with diameter of 30mm× length of 60mm is used, which is produced by Chi
Shenque was moxibussed with warm moxibustion apparatus for 15 minutes. Treatment frequency: 3 times per week. Duration: 4 weeks.

Sponsors

Acupuncture and Moxibustion Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) In line with the diagnostic criteria of moderate to severe perennial allergic rhinitis, TNSS total score =6 points; (2) Age 18-65 years old, gender is not limited; (3) Voluntarily participate in the clinical observation and sign the informed consent; (4) Be able to obey the doctor's treatment arrangements and cooperate with the doctor's treatment and follow-up; (5) The patient is sane, can correctly express the sense of moxibustion, behavior cooperation; (6) Voluntary test, signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with severe cardiovascular, cerebrovascular, liver, kidney, hematopoietic and other diseases; (2) Other nasal diseases, such as chronic rhinitis, sinusitis, nasal polyps, nasal septum deviation, etc.; (3) mental patients, pregnant or lactating women; (4) Merging patients with respiratory diseases such as asthma and bronchitis; (5) Dizzy moxibustion or moxibustion rejection; (6) People who are intolerant to Moxa tobacco.

Design outcomes

Primary

MeasureTime frame
TNSS;Serum IL-4;Serum IL-5;Serum 13;Serum cortisol;

Secondary

MeasureTime frame
RQLQ;RMS;Serum total IgE;

Countries

China

Contacts

Public ContactZhou Yu

Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Science

jimaike@126.com+86 135 2030 2630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026